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jABSTRACT
Baptisia tinctoria and Thuja occidentalis are reported to be immunostimulants, and thus
have an effect on white blood cells. Little formal research has been done to demonstrate
their effects on the different white cell populations. The purpose of this study was to
determine the effects of these substances on the circulating leukocytes, and to compare
these effects to a placebo. An initial full blood count was conducted to establish a
baseline level for each subject. The subjects were required to take 18.75 millilitres of the
medication or placebo in split doses over a three-hour period. Thereafter, a second full
blood count was taken at one-hour intervals. The medication appeared to cause an
increase in the lymphocyte count, thus suggesting a possible indication for viral infection.
There was an increase in both groups of the total WBC count as well as in the
lymphocyte count, raising the question of what substance actually caused these changes
to occur. Expansion of this study, including using a larger sample size and longer test
period, may be required to validate these results.
IV
ACKNOWLEDGEMENT
Thanks to
my Specialist Supervisor Mr Neil de Villiers for his constant guidance and
encouragement. His positive outlook on life is an encouragement to all around him.
my Supervisor Dr Liz Solomon for proof reading my research to see if it was viable from
a homoeopathic point ofview.
my fellow researchers for their collective input on my work.
Natura Laboratories for subsidising the medicines used in the research.
DDM Laboratories where the research tests were conducted
the Faculty ofHealth and Biotechnology for their essential financial assistance.
A special mention is needed for Mr Greg Khoury for his constant assistance and good
sense of humour as well as Mrs Elly Yelverton for proof reading this study and for
helping in it's general layout.
Finally, to my parents and friends, especially Andrew for many hours of assistance,
especially in putting his computer at my disposal, and to Vicki my very best friend,
without whose support I could not have completed this dissertation.
v
•TABLE OF CONTENTS
DEDICATION
DECLARATION
ABSTRACT
ACKNOWLEDGEMENT
TABLE OF CONTENTS
LIST OF TABLES
LIST OF FIGURES
CHAPTER 1. INTRODUCTION
CHAPTER 2. LITERATURE REVIEW
2.1 Immunity
2.1.1 Innate Immunity
2.1.2 Acquired Immunity
2.1.3 Different Types ofWBC's
2.1.3.1 Granulocytes
2.L3.2 Agranulocytes
2.2 Homoeopathy
2.2.1 Definition ofHomoeopathy
2.2.1.1 Law ofSimilars
2.2.2 Preparation ofHomoeopathic Medicine
2.2.3 Simplex and Complex Homoeopathy
PAGE
11
111
IV
V
VI
1
3
4
8
8
8
8
9
9
11
12
12
13
15
15
VI
2.3 Homoeopathic Medication 16
2.3.1 Baptisia tinctoria 16
2.3.2 Thuja occidentalis 18
CHAPTER 3. MATERIALS AND METHODS 22
3.1 Patient Requirement and Selection 22
3.2 Procedures 23
3.2.1 Methodology 23
3.2.2 Homoeopathic Intervention 25
3.3 Analysis of the Blood Samples 25
3.3.1 The Cell-Dynn 1700 CS Analyser 25
3.3.1.1 Open Mode 26
3.3.1.2 Pre-dilute Mode 27
3.3.1.3 White Blood Cell Analysis 27
3.3.1.4 Instrumental Rinse 28
3.3.2 Differential WBC Count 28
3.3.2.1 Preparation ofslide 28
3.3.2.2 Differential WBC Count 29
3.4 . Data Analysis 29
3.5. Statistical Analysis 30
CHAPTER 4. RESEARCH RESULTS 31
4.1 Total WBC Count 31
4.2 Granulocytes 34
4.2.1 Neutrophil count from CeU-Dynn 1700 CS 34
vii
4.2.2 Neutrophil count from manual differential 36
4.2.3 Eosinophil count from Cell-Dynn 1700 CS 38
4.3 Agranulocytes 40
4.3.1 Lymphocyte count from Cell-Dynn 1700 CS 40
4.3.2 Lymphocyte count from manual differential 42
4.3.3 Atypical lymphocyte count from manual differential 44
4.3.4 Monocyte count from manual differential 46
48
CHAPTER 5. DISCUSSION OF RESULTS AND CONCLUSION
5.1 Total WBC 48
5.2 Neutrophil count 49
5.2.1 Neutrophil count from Cell-Dynn 1700 CS Analyser 49
5.2.2 Neutrophil count from manual differential 49
5.3 Eosinophil count 50
5.4 Lymphocyte count 51
5.4.1 Lymphocyte count from Cell-Dynn 1700 Analyser 51
5.4.2 Lymphocyte count from manual differential 52
5.4.3 Atypical lymphocyte count 52
5.5 Monocyte count 53
5.6 Conclusion 53
5.7 Recommendation 53
VIII
REFERENCES
APPENDIX A
APPENDIXB
APPENDIXC
APPENDIXD
55
58
61
62
63
ix
LIST OF TABLES
Page
Table 1.1 FunctionofLeukoc~es 5
Table 4.1.1 Results ofTotal White Blood Cell Count 32
Table 4.1.2 Results of Comparisons Between Groups at Different Hours of 34
White Blood Cell Count
Table 4.2.1.1 Results ofNeutrophil Count from Cell-Dynn 1700 CS 34
Table 4.2.1.2 Results of Comparisons Between Groups at Different Hours of 35
Neutrophil Count from Cell-Dynn 1700 CS
Table 4.2.2.1 Results ofNeutrophil Count from Manual Differential 36
Table 4.2.2.2 Results of Comparisons Between Groups at Different Hours of 37
Neutrophil from Manual Differential
Table 4.2.3.1 Results ofEosinophil Count 38
Table 4.2.3.2 Results of Comparisons Between Groups at Different Hours of 39
Eosinophil Count
Table 4.3.1.1 Results ofLymphocyte Count from Cell-Dynn 1700 CS 40
Table 4.3.1.2 Results of Comparisons Between Groups at Different Hours of 41
Lymphocyte Count from Cell-Dynn 1700 CS
Table 4.3.2.1 Results ofLymphocyte Count from Manual Differential 42
Table 4.3.2.2 Results of Comparisons Between Groups at Different Hours of 43
Lymphocyte Count from Manual Differential
Table 4.3.3.1 Results ofAtypical Lymphocyte Count 44
Table 4.3.3.2
Table 4.3.4.1
Table 4.3.4.2
Page
Results of Comparisons Between Groups at Different Hours of 45
Atypical Lymphocyte Count
Results ofMonocyte Count 46
Results of Comparisons Between Groups at Different Hours of 47
Monocyte Count
2
LIST OF FIGURES
Page
Figure 4.1.1 Graph ofTotal White Blood Cell Count 31
Figure 4.2.1 Graph ofNeutrophil Count from Cell-Dynn 1700 CS 33
Figure 4.2.2 Graph ofNeutrophil Count from Manual Differential 36
Figure 4.2.3 Graph ofEosinophil Count 38
Figure 4.3.1 Graph ofLymphocyte Count from Cell-Dynn 1700 CS 40
Figure 4.3.2 Graph of Lymphocyte Count from Manual Differential 42
Figure 4.3.3 Graph ofAtypical Lymphocyte Count 44
Figure 4.3.4 Graph ofMonocyte Count 46
3
CHAPTERl
INTRODUCTION
Dr.Samuel Hahnemann a nineteenth-century German physician discovered
homoeopathy as a basis of therapy. Homoeopaths believe that if a substance is capable
of producing symptoms of disease in a healthy person, then this substance is capable of
eliminating these same symptoms when they occur in a disease condition. This is
known as the law of similars, the principle that like cures like (Vithoulkas, 1980).
It is further hypothesised that homoeopathic medicines work on the principle that they
stimulate the body's own defence mechanism, to improve or balance the immune
system's selfhealing reactions, and thereby obtaining a cure (Roy, 1994).
During infection, be it bacterial, viral or fungal, leukocytes become mobilised and
activated. This is not the case in immunocompromised people. Leukocytes are thus
involved in both cellular and humoral defence against foreign material (Jung et aI,
1992). There are five different types of leukocytes present in circulating blood and can
be distinguished from each other morphologically. The granulocytes, or
polymorphonuclear leukocytes, consist ofeosinophils, neutrophils and basophils and the
agranulocytes, or mononuclear leukocytes, consist of monocytes and lymphocytes
(Burkitt et aI, 1993).
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Each of these different cells has specific functions, which are summarised in the
following table.
TYPE OF FUNCTION OF LEUKOCYTES
LEUKOCYTES
Neutrophil Activated during bacterial infections
Eosinophils Activated during parasitic infection and allergic reactions
Basophils Are found in the tissues and activated during anaphylactic
response
Lymphocytes Activated against viral and bacterial infections
Monocytes Acts in phagocytosis of foreign matter
Table 1.1 Functions of leukocytes (Moffet et ai, 1993).
Antibiotics are chemical substances produced from various micro-organisms that kill or
suppress the growth of other micro-organisms. Antibiotics are widely used in different
types of infections. Their efficacy, when used selectively, causes a change to the face of
modem medicine, in that illnesses like TB, cholera, pneumonia and life threatening
diseases were made manageable and has decreased the mortality rates caused by them
through the use of antibiotics. But side effects ranging from diarrhoea to systemic
toxicity have led to the consideration of other alternatives. Since antibiotics have been
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used the problem of superinfectionhas developed. This is an infection that occurs during
the course of antibiotic therapy especially where either large doses or broadspectrum
antibiotics are used (McKenry et aI, 1998). Thus, it can be seen that misuse ofantibiotics
has led to a decrease in their overall efficacy.
" In no case under treatment is it necessary and therefore not permissible to administer to
a patient more than one single, simple medicinal substance at one time." This quote
taken from the Organon of Medicine (1883) written by Dr. Samuel Hahnemann
illustrates the fact that historically and classically homoeopaths has been treating
patients with one single dose ofone single remedy and that the use of complex remedies
has only come into use in more resent times. According to McKenna (1996) complex
homoeopathy (where more than one remedy is combined into one pharmaceutical
preparation) is more rapid in action than that of a single remedy. The homoeopathic
theory, especially the use of complex remedies as an alternative, is worthy of further
scientific research. Low potencies has a greater pharmacological action (Jouanny, 1994)
and are therefore more suited for use in compound formulations.
This study made use of a complex formulation of Baptisia tinctoria mother tincture and
Thuja occidentalis Dl. Baptisia, also known as Wild Indigo, can be traced back to the
North American Indians who used this for the treatment of infections, bruises and
wounds. Presently it is used for its immune enhancing ability, anti-cattarhal and anti-
microbial effects. It prevents the multiplication of bacteria and fungi and thus has a
beneficial action in the treatment of all infections, both chronic and acute. McKenna
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(1996) has claimed that an oral administration of Baptisia tinctoria has shown a 30%
increase of leukocytes within two to three hours. The levels of lymphocytes were.
activated more than other white blood cells, which indicates the suitability of this
substance in the treatment ofviral infections.
Thuja occidentalis was used from as early as in the sixteenth century in Europe, its main
use being for the treatment of warts in the form of external applications. It is presently
used internally for its anti-viral properties (McKenna, 1996).
A complex combination of Thuja occidentalis DI and Baptisia tinctoria mother tincture
was used over a three hour period, on a group of 18 subjects in the experimental and 36
subjects in the control groups. Prior to the administration of the experimental and
placebo substances a full blood count was taken and a second blood was taken after
completion of administration. Another two full blood counts were taken at hourly
intervals after the second full blood count. The aim of this study was thus to see if
circulating leukocytes would increase with the administration of Thuja occidentalis DI
and Baptisia tinctoria mother tincture.
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CHAPTER 2
LITERATURE REVIEW
2.1 Immunity
2.1.1 Innate Immunity
The human body's ability to resist almost all organisms or toxins is called immunity.
Immunity can be divided into two groups: acquired and innate immunity. Innate
immunity results from general processes that occur in the body, including phagocytosis
of foreign bodies like bacteria by white blood cells and destruction of foreign matter by
acid secretions in the stomach. The skin acts as a natural barrier to invading organisms
and chemical compounds in the blood that attaches to and destroys foreign organisms or
toxins (Guyton, 1993).
2.1.2 Acquired Immunity
Acquired immunity is an extremely powerful and specific type of immunity. It acts
against individual invading agents ranging from bacteria, viruses, fungi, toxins or even
foreign matter from animals. There are two types of acquired immunity occur in the
body, namely humoral immunity or B cell immunity where the body develops
circulating antibodies capable of attacking invading agents and cell mediated immunity
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or T cell immunity where activated lymphocytes are formed specifically to kill the
foreign agent (Guyton, 1993).
The cells responsible for acquired immunity, and thus capable of destroying bacteria,
viruses, toxins and fungi, are white blood cells or leukocytes. They are formed partially
in the bone marrow and partially in the lymph tissue. Leukocytes are especially of value
because they travel in the blood to areas of serious inflammation and provide a strong
and quick defence.
2.1.3 Different types ofWhite Blood Cells
Six different types of white blood cells are normally found in the blood.
Polymorphonuclear cells consist ofneutrophils, basophils and eosinophils. Mononuclear
cells consist of lymphocytes, monocytes and also plasma cells of which only a few are
found in the blood (Guyton, 1993).
2.1.3.1 Granulocytes
Granulocytes, another name for polymorphonuclear cells, are larger than erythrocytes.
They have lobed nuclei and the granules in their cytoplasm stain with Wright's stain.
Neutrophils consist of more than 50% of the leukocyte population. They have nuclei
consisting of 3-6 lobes and the cytoplasm stains pale lilac and contains fine granules that
are difficult to see. Some of the granules in the cytoplasm contain hydrolytic enzymes
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and other peroxidases and are classified as lysosomes. The smaller granules contain a
potent "mixture" of antibiotic-likeproteins called defensins. Neutrophils are chemically
attracted to sites of inflammation and then actively phagocytose. They are especially
attracted to bacteria, which they ingest and destroy, therefore neutrophil numbers
increase drastically during acute bacterial infections like meningitis and appendicitis.
Neutrophils have a life span of six hours to a few days (Marieb, 1992).
Eosinophils consist of 1-4%ofall leukocytes and are about the same size as neutrophils.
The cytoplasm stains from brick red to crimson with large granules. The nucleus looks
like an old fashioned telephone receiver. They have two lobes connected by a broad
band. The granules in the cytoplasm are filled with different digestive enzymes of which
the main functions are the killing of parasitic worms like flatworms and roundworms
that are too large to be phagocytozed, and the destruction of some antigen-antibody
complexes. It also inactivates some inflammatory chemicals of allergy. They have a life
span ofeight to twelve days (Marieb, 1992).
Basophils are the rarest of the leukocytes making up only 0.5% of the leukocyte
-population. The cytoplasm has large coarse histamine containing granules that acts as
vasodilators and attracts other leukocytes to the inflamed site. Basophils are the same
size or slightly smaller than neutrophils. The nucleus is deep purple in colour and
generally S or U shaped with two or three constrictions. They have a life span of
between a few hours to a few days (Marieb, 1992).
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2.1.3.2 Agranulocytes
Mononuclear leukocytes, also called agranulocytes, have cytoplasms with no visible
granules.
The second biggest group of leukocytes is called lymphocytes with large numbers found
in the body but only a small number found in the blood stream. These leukocytes are so
called because most are found and are active in lymphoid tissues like the lymph nodes,
spleen and thymus gland (Marieb, 1992). T lymphocytes are responsible for cell
mediated immunity so that when they come into contact with virus infected cells they
become activated and form T cells. B lymphocytes are responsible for humoral
immunity so that when they come into contact with virus infected cells they form plasma
cells, which in tum forms antibodies. Both the T cells and antibodies react in tum in a
highly specific way against the antigen that caused their initial development. The
mechanism is as follows: at least a million preformed T and B lymphocytes are found in
the body, but when they are activated they are capable of forming only one type of
antibody or T cell with a single type of specificity. The specific antigen against which it
will act, will therefore be the only stimulus that will activate it. As soon as the antigen
has activated the specific lymphocyte, it reproduces rapidly to form large numbers of
duplicate lymphocytes (Guyton, 1993).
The nucleus has a spherical shape that fills most of the space in the cell. It stains dark
purple and is usually spherical in shape and is surrounded by a thin rim of pale blue
cytoplasm. The life span ofa lymphocyte can range from hours to years.
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Monocytes are the largest of the leukocytes, have an abundance of blue-gray cytoplasm
with the nucleus shaped in a characteristic U or kidney shape. They travel from the
blood stream into the tissues where they differentiate into macrophages. When they
come into contact with chronic viral infections there is an increase in macrophage
numbers. They then actively phagocytose these viruses, as well as playing a roll in
activating lymphocytes to mount an immune response (Marieb, 1992).
It can thus be concluded that the leukocyte population of the body is essential for human
immunity, in that anything that can cause an increase in the leukocyte population will
lead to an increased strength in immunity. If medication can lead to an increase in
circulating leukocytes, then this medication will lead to a strengthened and improved
immunity.
2.2 Homoeopathy
It has been claimed that the use of Baptisia tinctoria mother tincture and Thuja
occidentalis Dl, two remedies, used frequently by homoeopaths, have certain anti-viral
and anti-bacterial properties (McKenna, 1997). It was therefore deemed valuable to
conduct research to determine how these remedies when used in combination would
affect circulating.
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2.2.1 Definition ofHomoeopathy
Homoeopathy is a therapeutic method which clinically applies the law of similars and
which uses medicinal substances in dilute or infinitesimal dosis. Samuel Hahnemann
(1755-1843) is considered to be the father of homoeopathy. He tested many medicinal
. substances such as Peruvian bark and Belladonna on healthy human beings. The
medicine in each substance was diluted until toxic effects on the individual were
irradicated (Eizayaga, 1991). This was conducted in order to ascertain the non-toxic but
dynamic effect of the medicinal substance on the individual. Samuel Hahnemann first
tested Peruvian Bark on himself and experienced changes to his subjective state of
health similar to the symptoms of intermittent fever. When he stopped taking Peruvian
Bark these symptoms disappeared. This led to the testing of medicine on healthy
subjects (Koehler, 1983). The law of similars was thus formed after the testing of drugs
on healthy subject and noting that the symptoms a medicine induced in healthy subjects
would beused to cure those same symptoms in an ill patient.
2.2.1.1 Law ofSimilars
The law of similars states the symptoms of illness a medicine causes in a healthy
individual can cure that same illness in a sick individual. In paragraphs 26 and 27 of the
Organon of Medicine, considered to be the bible of homoeopathy, Halmemann defines
the laws of homoeopathy as follows - "A dynamic illness in the living organism is
overcome and destroyed in a durable form by another stronger one, always provided that
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this stronger one, without being ofthe same species as the other, resembles it much in its
manifestations".
The curative power of medicament are derived from the fact that they in themselves,
produce similar symptoms to those of the illness and contain an energy superior to those
symptoms." (Eizayaga,1991).
Simply explained, homoeopathic medicines enhance the body's natural healing powers
(McKenna, 1997). Homoeopathy thus acts by stimulating the body's defence
mechanisms so as to make them work more effectively (Jouanny, 1994). The medicines
are very safe, and even in newborn babies they have no side effects (McKenna, 1997).
Homoeopaths believe that a comprehensive definition of health must fit the entire scope
ofthe human being. This means that the person must be treated holistically at alllevels -
mentally, emotionally and physically. Homoeopaths thus believe that the human
organism works as a totality. The body's defence mechanism creates the best defence
possible and tries to limit symptoms to the most peripheral levels, the mental level being
the deepest, followed by the emotional level, and then the most superficial level, the
physical level (Vitoulkas, 1980).
It is thus believed that the immune system is not only limited to the physical level, but is
influenced by both the mental and emotional levels. The vital force acts as the immune
system when the person is ill. (Vitoulkas, 1980).
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To call this a homoeopathic study would therefore not be completely true, as the only
measurements taken were on the physical level, with medicines prepared according to
homoeopathic principles, but used more for their herbal than their homoeopathic
properties.
2.2.2 Preparation ofhomoeopathic medicine
Homoeopathic medicines are made from matter found in the plant, mineral and animal
kingdoms. The preparation of medicine is done through set methods under strict control
measures. If a substance is obtained from the plant kingdom, as with the medicines used
in the research, a mother tincture is obtained from the raw plant and this product is then
diluted in 90% alcohol to preserve it, and in 20% alcohol if to be ingested (Eizayaga,
1991).
For the research Baptisia tinctoria was used in its mother tincture and Thuja occidentalis
was used in the Dl (decimal) strength. This means that a mother tincture was prepared
from Thuja. One drop was taken from the mother tincture and placed into a jar with
nine drops of alcohol (90% if it is to be preserved and 20% if to ingested). The jar was
then succussed by placing it in one hand and beating it against a plastic body 10 times.
The Dl potency thus equals 1/10 = 10-1 of the original substance (Eizayaga, 1991). The
medication and placebo used in this research was obtained from Natura Laboratories the
manufacturing procedures are noted in Appendices C and D.
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2.2.3 Simplex and Complex Homoeopathy
Homoeopathy can be divided into simplex and complex homoeopathy. Simplex
homoeopathy is based on the use of a single remedy, usually in a high potency. The
remedy is prescribed on the basis of information obtained from a detailed patient case
history, and an attempt is made to match the patient's symptoms with the remedy's
symptom picture. Complex homoeopathy (which was used in the research) is based on
using more than one remedy at a time. This approach is very popular in Europe and is
used especially because it is claimed to work more rapidly than simplex homoeopathy
(McKenna, 1997). Equal doses of Baptisia tinetoria mother tincture and Thuja
oecidentalis DI were used in the research, making use ofcomplex homoeopathy.
2.3 Homoeopathic Medication
2.3.1 Baptisia Tinetoria
Baptisia tinetoria was used in its mother tincture as no known side effects have been
"noted for using this remedy in this state. It has been used for centuries by the indigenous
North Americans and later in Europe as medicinal herb. Since the mid-1800's it has
been used in Germany as homoeopathic medicine (McKenna, 1997).
Baptisia tinctoria is made from the root of the Wild Indigo a plant from the
Luguminosae family (Jouanny, 1994). This remedy is used in serious infections where
there is a rapid onset of a septic state. Generally a strong sensation of pain and general
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stiffuess is felt allover the body accompanied by putrid offensive discharges and the
face has a stupid, besotted look with red dusky congestion. This remedy is prescribed for
diarrhoea, influenza, mastoiditis, pharyngitis, sepsis and tonsillitis (Morrison, 1995). It is
also prescribed for severe infectious syndromes, and before the discovery of antibiotics
this was the remedy prescribed for cases of typhoid fever (Jouanny, 1994). It is noted
that because of its anti-cattarhal action the remedy is most useful for respiratory tract
infections, especially where there are large amounts of catarrh produced (McKenna,
1997).
McKenna (1997) claims that Baptista has an antibiotic-like effect on a wide range of
microbes. It kills the microbe and prevents it from multiplying in the body. He claims
that it has an immune enhancing effect, and that when taken orally as a tincture,
alcoholic extract or in homoeopathic preparation, it can lead to a 30% increase in the
number ofleukocytes within 2-3 hours oftaking the substance (McKenna, 1997).
Results from research done in 1991 by Egent and Beuscher showed characteristic
antigen antibody specificity that was obtained from arabinogalactan proteins which had
been extracted from Baptisia, thus showing that Baptisia contains definitive
immunomodulating compounds (Egent et aI, 1991).
Further research indicates that lymphocytes are the leukocytes most activated by
glycoproteins from this plant extract. This indicates the effectiveness that this substance
should have on viruses (McKenna, 1997).
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When used as a homoeopathic medicine, this remedy is used for septic conditions of the
blood, malarial poisoning and extreme prostration. There is great muscular soreness and
all discharges and secretions are offensive, such as breath, urine and stools. The person
is tremulous and weak, is mentally restless, but too lifeless to move. Mentally there is
confusion. The person thinks he is broken and tosses about the bed, trying to get pieces
of his body together. There is a dull feeling in the occiput and the scalp feels sore.
When looking atthe face, there is a dusky, besotted look with dropping of the lower jaw.
The tongue feels burnt and is yellowish-brown with the edges being red and shiny. He
has no appetite, with a constant desire for water. There is a sinking sensation in the
stomach with belching of large amounts of wind. Painful vomiting follows nausea and
eructations. There is pain over the region of the gall bladder with diarrhoea, with the
abdomen being distended and rumbling. Stools are very offensive, thin, dark and bloody.
There is stiffness in all joints as if the joints have been strained. The person is sleepless
and restless, with rheumatic pains all over the body. This remedy is usually prescribed
for adynamic fever, such as typhus fever and gastric influenza (Vermeulen, 1997).
2.3.2 Thuja occidentalis
Thuja occidentalis is made from fresh green twigs from the Arbor Vitae tree that belongs
to the Coniferae family. This tree is also known as the tree of life (Gibson, 1987). It is
cultivated in Europe as a garden plant and became well known medicinally as a
homoeopathic preparation. When taken internally in herbal form Thuja was found to
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have severe side effects, causing abortion in pregnant women. These side effects are
absent when used in infinitesimal doses.
A great deal of research has been done on the external uses of Thuja occidentalis. As far
back as in 1838, a Dr. Warnatz reported the cure ofpreviously unresponsive warts on the
penis and scrotum, with an external application of Thuja (McKenna, 1997).
In 1972 an article in the British Homoeopathic Journal reported cases of epilepsy,
asthma, boils, dermatitis and previously untreatable headaches that occurred after
multiple or unsuccessful vaccinations which had all been treated successfully with Thuja
occidentalis (Tyler, 1972). Vaccination has been reported in certain cases to cause
severe side effects in the above mentioned cases. With vaccinations a small dose of the
original strain is injected into the body. Pitcairn (1995) states that the percentage of the
number ofcases ofdiseases, such as Measles, diagnosed in the United States, was higher
in people who had been vaccinated than in those who had not been vaccinated.
In 1995 another article reinforced the efficacy of treating conditions that had arisen after
or as a result of vaccination. It also noted the success obtained in treating chronic
ailments of the skin and in general in the treatment of viruses. This article noted the
efficacy in treating these conditions in both humans and animals (Pitcairn, 1995). The
articles by Pitcairn and Tyler indicate the effect of Thuja occidentalis in the treatment of
side effects resulting from vaccination.
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A research article was published in a journal called Immunology Letters in 1996. TPSg,
an anti-HIV-l agent, which is an agent isolated in Thuja occidentalis (in crude form)
was seen to enhance in vivo hemopoietic progenitor cells in sublethally irradiated mice.
Its success in stimulating the production of several hemopoietic cytokines and stromal
precursor cells which had been successfully used in clinical studies to ameliorate the
Hl'V disease and enhance the host defence against opportunistic AIDS patients was of
great significance (Hassan et aI, 1996).
The main indications for Thuja occidentalis when used homoeopathically, range from
genital conditions such as vesical polyps, ovarian cysts and sclero-cystic ovaritis to
cutaneous indications such as warts, juvenile acne, boils, seborrhic alopecia and
conditions ranging from neuralgia to asthma and rheumatism (Jouanny, 1994).
Vermeulen (1997), states the following uses for Thuja occidentalis when used in
homoeopathic form. It has a specific antibacterial reaction as in gonorrhoea and
vaccination particularly where there is rapid exhaustion and emaciation, discharges
being foul with a musty or sweetish odour. On the mental level its uses are for emotional
sensitivity with crying because of listening to music; always hurrying, and becoming
overexcited or anxious about trifles; anger from contradiction, vanishing of thoughts
while speaking and worrying about salvation. The remedy is prescribed for sufferers of
headaches, with a sensation of being hit by a nail through the vertex; a constant feeling
of pressure and dryness on the eyes, dim vision, as if covered by a veil, or from mist.
Thuja occidentalis is prescribed for chronic otitis with purulent putrid discharges. It is
also prescribed for warts on the nose, and where there is soreness and ulceration of the
nostrils; dryness of the throat with painful swelling, and hawking up of mucus occurring
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with great difficulty; lack of appetite because of mental depression - a craving for
chocolate alternates with a lack of appetite; cutting pain in the pit of the stomach, with
retching and loud belching - examination of the abdomen gives the impression that
something alive is moving in it; swollen piles that bum at the anus; daily diarrhoea in the
morning; pain and burning felt near the neck of the bladder, with a frequent desire to
urinate; during menses for a bearing down sensation. This remedy is prescribed for
asthma in children; a dry, hacking cough in the afternoon; visible palpitations appearing
without anxiety; sufferers ofpersistent insomnia-with dreams ofdeath; intermittent fever
and-gonorrhoealinfection.
It is thus seen that when the symptoms fit Thuja is frequently used for viral infections,
occurring both internally and externally (McKenna, 1997).
It can therefore be surmised that both Thuja occidentalis and Baptisia tinctoria should
have an effect on the number of circulating leukocytes when combined in a complex
form.
to successfully study this medication in a homoeopathic form, further research must be
conducted using higher potencies (which have been diluted and succused beyond
Avagadro's number).
In conclusion, this research uses the medicines prepared according to homoeopathic
methods, which measure the pharmacological effects of these substances on circulating
leukocytes.
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CHAPTER 3
MATERIALS AND METHODS
3.1 Patient requirement and selection
An advertising campaign, through placing of posters on campus, was launched at the
TWR, in order to recruit subjects. The posters contained basic information about the
nature of the research and also contact numbers. Subjects were then supplied with
explanatory letters about the research as well as what was expected of them, should they
choose to participate in the research (see Appendix A). Due to logistic reasons the
subjects were required to be residents of urban areas of the Gauteng province in South
Africa The study required that the subjects must not have been taking any
immunostimulant therapy of phytotherapeutic or homoeopathic origin at or prior to the
study. Furthermore subjects could not have a history of alcoholism, as the medication
contained 20% alcohol. The study only used subjects whose initial Full Blood Count fell
within the normal reference range calculated by the Cell-Dynn 1700 analyser. The study
was done using a total of 54 volunteers, all above the age of 18 and consisting of equal
numbers of both sexes. The study was done in conjunction with two other studies using
different medicines, but in the same environment and at the same time, so that the
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control group was shared. The suitable subjects all signed a "Patient Consent Form" (see
Appendix A). The consent form and explanatory letter was approved by the Committee
for Research on Human Subjects (Medical) of the Technikon Witwatersrand,
Johannesburg (protocol number: EC5/98/022).
3.2 Procedures
3.2.1 Methodology
The study was conducted in a double-blind placebo-controlled manner. DDM
Laboratory randomly divided the subjects into two groups namely a control group and
an experimental group. A total of 17 of the 18 subjects in the experimental group
completed the research while 36 subjects in the control group completed the research.
To identify the subjects, DDM Laboratory randomly allocated each subject an identity
number. Volunteers served as their own control, because a baseline full blood count with
differential was done before administering the complex formula.
All bottles containing either the placebo or experimental substances were labeled
identically by the manufacturer and then subsequently labeled with an identity number
by DDM Laboratory. On the morning ofthe research, subjects were given the numbered
bottle that corresponded with their identity numbers. Neither the subjects nor the
researcher knew who received the placebo or experimental substance until the analysis
stage ofthe study.
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Environmental factors as external variables which could cause changes in circulating
leukocytes were eliminated as the research was conducted concurrently in the same
environment for both groups of subjects. Each subject received the same quantity at the
same time intervals ofboth experimental and placebo substances.
Instructions on how to take the medication orally were given to all subjects. Equal doses
ofmedication in liquid form were given toeachgroup.~Abloodsample_wastaken to do
the-initial full blood count, after which thefirst dose-of a 100 drops of the-medication or
placebo was administered. Subsequently three doses of 50 drops were taken at 45 minute
intervals. Medication or placebo was thus taken over a three hour period with a total of
300 drops administered under supervision of the supervisor and researcher. Using the
scale of one millilitre being equal to sixteen drops, the total volume of medication or
placebo administered was thus 18.75 millilitres. After the last dose of medication or
placebo was taken a second full blood count was done. Then another two full blood
counts were done for each subject over the five hour trial period.
Blood samples were drawn by a phlebotomist appointed by DDM Laboratory. The blood
was collected in ethylenediaminetetraacetic acid (EDTA, which binds the calcium in the
blood that then prevents clotting of the blood) vacutainers with each tube labelledwith
the identity number of the subject and the time of collection (Bishop et al, 1996). SA
Scientific supplied all needles and vacutainers. To sterilise the venupuncture site prior to
the withdrawal of a sample a 75% ethanol solution was used. Where possible the blood
samples were drawn from different vein sites, except when the subject only had one or
two veins easily accessible for venupuncture.
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The blood samples were analysed for Full Blood Count purposes using the Cell-Dynn
1700 analyser. A full blood count is a test that quantitatively measures the different
blood cells in defined ranges determined by each individual laboratory.
3.2.2 Medicinal intervention
The complex medication used in the study consisted of equal parts (50% each) of
Baptisia tinctoria mother tincture and Thuja occidentalts Dl potency. Both medicines
were prepared according to standard homoeopathic manufacturing procedures by Natura
Homoeopathic Laboratories and presented in 25 millilitre amber glass bottles. Natura
also manufactured the placebo substance to ensure a standard appearance, consistency,
smell- and taste. The-contents of the-placebo is noted in Appendix C, this information
was obtained from Natura Homoeopathic Laboratories on the 1st of July 1999.
3.3 Analysis of the blood samples
3.3.1 The Cell-Dynn 1700 CS analyser
All blood samples collected were analysed Using the Cell-Dynn 1700 analyser.
Leukocyte, erythrocyte and platelet data is determined using the electrical impedance
method, while the modified cyanmethoglobin method is used to determine haemoglobin
data. During each cell count before each parameter-is measured the sample is aspirated,
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diluted and mixed. The analyser produces a CD 1700 specimen data report that includes
the total leukocyte count, haemoglobin levels, haematocrit, mean cell volume, mean cell
haemoglobin concentration, RDW, platelet count and the mean platelet volume (see
Appendix A). This report also includes the normal reference range for the sample.
3.3.1.1 Open mode
To aspirate thirty microlitres ofwhole blood from a collection tube that has been opened
and held under the sample aspiration probe, the analyser uses the open mode. During the
dilution process a 7.5 millilitre volume of dilutent is added in the pre-mixing cup to
achieve a ratio of 1:251. After dilution the substance is then divided into two samples.
100 microlitres ofthe 1:251 sample dilution are aspirated and mixed with an additional 5
millilitres of dilutent in the-RBC/PLT mixing chamber to a 1:1280 1 ratio. This dilution
is used to analyse the red blood cell and platelet parameters. The remainder of the 1:251
dilution is mixed with 1.0 ml of lyse reagent in the WBC mixing chamber. The lyse
reagent ruptures the membrane of each red blood cell, causing the quick release of
cytoplasm and haemoglobin. The remaining red cell membrane (ghost) is less than two
femolitres.
The lyse reagent not only ruptures the erythrocyte membrane but also compresses the
membrane of each leukocyte. This compression causes' cytoplasm to diffuse slowly from
the cell as the membrane shrinks around the nucleus and any cytoplasmic granules
present. The dilution is-then used to measure the number-and modified size of the white
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blood cells and the amount of haemoglobin released. In both the WBC counting
chamber and the RBC counting chamber, volumetric metering is used, to ensure that a
precise amount ofdiluted specimen is measured during each count cycle.
3.3.1.2 Pre-dilute mode
In the pre-dilute mode whole blood is pre-diluted to a ratio of 1:251 using 40 microlitres
of sample to 10 millilitres of dilutent, and is then poured into the pre-mixing cup. The-
sample is then processed in the same way as the open mode.
3.3.1.3 White Blood Cell analysis
To count the leukocytes as they pass through the aperture in the Von Behrens WBC
transducer, electrical impedence is used. The change in electrical resistance that occurs
as each cell is drawn through the aperture generates an equivalent voltage pulse. The
number of pulses sensed during each cycle corresponds to the number of white blood
cells counted. The amplitude of each pulse is directly proportional to the cell volume.
Electronic sizing is used to determine three distinct white cell subpopulations. The small
cell subpopulation includes cells correlating to lymphocytes, while cells correlating to
neutrophils are included in the large cell population. The remaining cells correlating to
monocytes, basophils, eosinophils, blast and other white cell precursors are generally
included in the mid-size cell population.
27
3.3.1.4 Instrumental rinse
Each element of the instrument is rinsed after each count cycle. The open sample
aspiration probe is rinsed externally with dilutent and internally when the dilutent is
dispensed. The Von Behrens WBC is also rinsed with dilutent.
3.3.2 Differential white blood count
3.3.2.1 Preparation ofthe slides
Using the rapid haematology stain a microscopy slide was made for each blood sample.
The reagents included a fixative (stained green for easy identification), an eosin stain
(red solution), a methylene blue stain (blue solution) and a solution of Sorensen's
phosphate buffer solution (pH 6.8).
The slides were prepared as follows:
1. After slides had dried they were dipped into the fixative five times. The duration of
each dip was one second.
2. Any excess fixative was drained and not blotted.
3. The slides were then dipped into the eosin stain five times. The duration of each dip
was one second.
4. Any excess eosin stain was again drained.
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5. The slides were dipped into the methylene blue stain five times. The duration of each
dip was one second.
6. Any excess methylene blue was drained and not blotted.
7. The slides were then rinsed in a container containing a fresh solution of Sorensens
buffer (pH 6.8).
8. The slides were then rinsed off under slow running water until they were clean of
any excess stains.
9. The slides were then placed vertically and allowed to air-dry.
3.3.2.2 Differential WBC count
Each slide was then examined microscopically in DDM Laboratory by the researcher.A
differential white cell count was performed using a Olympus BHZ microscope with a
50x magnification oil immersion lens. A DBC 9 manual counter was used to calculate
absolute values for segmented cells, band cells, lymphocytes, eosinophils, monocytes
and basophils. Data was recorded on data sheets.
3.4 Data analysis
A database on Microsoft Access to analyse data obtained was written by the supervisor.
Data was then presented in group format in Sigma Plot.
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3.5 Statistical analysis
The data collected was statistically analysed. This was done under supervision of a
statistician. A mean was calculated for each group and the standard deviation was
determined. The Wilcoxon Signed Rank Test and the Mann-Whitney Rank Sum Test
was used to compare the difference within the groups. The Mann-Whitney Rank Sum
Test was also used to compare the difference. between. the. groups e, The.hypotheses were
tested.
The Wilcoxon Signed Rank tests the null hypothesis that two samples were drawn from
populations with the same medians, It is a nonparametric procedure, which does not
require assuming normality Or equal variance. The test ranks all the observed treatment
differences from smallest to largest based on their absolute value and then attaches the
sign ofeach difference to the nmks.
The Mann-Whitney Rank Sum Test is used to test the null hypothesis that two samples
were not drawn from populations with different medians. It is' a nonparametric
procedure, which does not require that you assume normality or equal variance. The test
ranks all the observations frorn smallest to largest without regard to which group each
observation comes from. The ranks for each group are summed and the rank sums
compared.
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CHAPTER 4
RESEARCH RESULTS
In this study, according to stated delimitations, only subjects whose first white cell count
fell within the stated accepted normal range were used. Using this criterion as a
guideline no data of any volunteer was regarded as invalid, and discarded.
4.1 Total WBC Count
Figure 4.1 . Graph of Total White Blood Cell Count
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Table 4.1 Total White Blood Cell Count Results
WILCOXON SIGNED RANK TEST MANN-WHITNEY RANK SUM TEST
EXPERIMENT CONTROL EXPERIMENT GROUP CONTROL
GROUP GROUP GROUP
0-3 hours <0.05 <0.01 >0.05 >0.05
0-4 hours >0.05 <0.01 >0.05 <0.05
0-5 hours <0.01 <0.01 <0.01 <0.05
3-4 hours >0.05 >0.01 >0.05 >0.05
3-5 hours >0.05 >0.05 >0.05 >0.05
4-5 hours >0.05 >0.05 >0.05 >0.05
The raw data (See figure 4.1), was subjected to analysis using the Wilcoxon Signed
Rank Test. Comparison of data from the zero hour to three hour sample revealed a
statistically significant difference (p = < 0.05), indicating a relative increase in the
number of cells between the baseline results, and the three hour results in the
experimental group. There was also a statistically significant difference between the
zero and five hour samples (p =< 0.05). There was, however, no significant difference
between the zero and four hour sample. There was also no difference indicated in the
three to four, three to five and four to five hour samples (p => 0.05).
There was, however, a statistically significant difference between the samples zero to
three, zero to four and zero to five hours in the control group (p = < 0.05). There was
also a statistically significant difference between the three and four hour samples in the
control group (p = > 0.01), thus reflecting an increase in the number of cells. The three
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to five and four to five hour samples in the control group did not, however, show any
statistically significant difference (p =>0.05).
The same comparative data was then conducted using the Mann-Whitney Rank Sum
Test. No statistically significant differences were seen between any of the groups (p =
>0.05), but the zero to five hour group in the experimental group and the zero to four
and zero to five hour group in the control group showed statistically significant
differences. The Mann-Whitney Rank Sum Test was also used to compare the diffe rent
sample times in the control and experimental group but this revealed no statistically
significant difference (p = >0.05).
Figure 4.1.2. Graph of Neutrophil Count from Cell-Dynn 1700 CS
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Table 4.1.2 Results ofComparisons Between Groups at
Different Hours of White Blood Cell Count
SAMPLE HOURS MANN-WHITNEY RANK SUM TEST RESULTS
COMPARED
ohours NO - >0.05
3 hours NO->0.05
4 hours NO ->0.05
5 hours NO - >0.05
4.2 Granulocytes
4.2.1 Neutrophil Count from Cell-Dynn 1700 CS
Table 4.2.1.1 Results OfNeutrophil Count From Cell-Dynn 1700
Wn..COXON SIGNED RANK TEST MANN-WHITNEY RANK SUM TEST
EXPERIMENT CONTROL EXPERIMENT CONTROL
GROUP GROUP GROUP GROUP
0-3 hours >0.05 <0.05 >0.05 >0.05
0-4 hours >0.05 <0.01 >0.05 >0.05
0-5 hours <0.05 <0.01 >0.05 >0.05
3-4 hours >0.05 >0.05 >0.05 >0.05
3-5 hours >0.05 <0.01 >0.05 >0.05
4-5 hours >0.05 >0.05 >0.05 >0.05
34
The raw neutrophil data (See Figure 4.2.1), was subjected to analysis using the
Wilcoxon Signed Rank Sum Test. Comparisons were done at zero hours, three hours,
four hours and five hours and showed no statistically significant difference (p = >0.05)
but the zero to five hour sample in the experimental group showed statistically
significant differences as well as the zero to three, zero to four and zero to five hour
samples in the control group (p = <0.05).
The Mann-Whitney Rank Sum Test was used to compare and analyse the data in the
same way but no statistically significant differences were seen between any of the
groups analysed (p = >0.05) including the comparisons done between the experimental
and the control groups.
Table 4.2.1.2 Results of Comparisons Between Groups at Different Hours
ofNeutrophil Count from Cell-Dynn 1700
SAMPLE HOURS MANN-WHITNEY RANK SUM TEST RESULTS
COMPARED
ohours NO ->0.05
3 hours NO ->0.05
4 hours NO ->0.05
5 hours NO ->0.05
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4.2.2 Neutrophil count from manual differential
Figure 4.2.2. Graph of Neutrophil Count from Manual Differential
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Table 4.2.2.1 Results of Neutrophil Count from Manual Differential
WILCOXON SIGNED RANK TEST MANN-WHITNEY RANK SUM TEST
EXPERIME T co TROL EXPERIMENT co TROL
GROUP GRO UP GROUP GRO UP
0-3 hours >0.05 <0.01 >0.05 >0.05
0-4 hours >0.05 <0.05 >0.05 >0.05
0-5 hours >0.05 <0.01 >0.05 >0.05
3-4 hours >0.05 >0.05 >0.05 >0.05
3-5 hours <0.01 >0.05 >0.05 >0.05
4-5 hours >0.05 >0.05 >0.05 >0.05
36
The Wilcoxon Signed Rank Test was used to analyse the raw data (See figure 4.2.2).
Comparisons of samples drawn at zero, three, four and five hour groups were conducted
showing a statistically significant difference between the zero to three and zero to five
hour groups (p = <0.01). And also between the zero to four and three and five hour
group (p =<0.05) in the control group.
The same comparative data analysis was then conducted using the Mann-Whitney Rank
Sum Test. This revealed no statistically significant data between any of the groups
analysed (p = >0.05). This test was also used to compare the medication and placebo
groups at the different time intervals and showed statistically significant results between
zero hours medication group and zero hours control group (p = <0.01) but showed no
statistically significant difference between any of the other groups compared (p =
>0.05).
Table 4.2.2.2 Results of Comparisons Between Groups at
Different Hours ofNeutrophil from Manual Differential
SAMPLE HOURS COMPARED MANN-WHITNEY RANK SUM TEST RESULTS
ohours YES - <0.01
3 hours NO ->0.05
4 hours NO ->0.05
5 hours NO ->0.05
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4.2.3 Eosinophil count from Cell-Dynn 1700 CS
Figure 4.2.3. Graph of Eosinophil Count
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Table 4.2.3.1 Results of Eosinophil Count
WILC OXON SIGNED RANK TEST MANN-WHITNEY RANK SUM TEST
EXPERIMENT CONTROL EXPERIM E T CONT ROL
GRO UP GRO UP GRO UP GROUP
0-3 hours >0.05 >0.05 >0.05 >0.05
0-4 hours >0.05 >0.05 >0.05 >0.05
0-5 hours <0.01 >0.01 <0.01 <0.05
3-4 hours >0.05 >0.05 >0.05 >0.05
3-5 hours <0.01 <0.01 <0.01 <0.05
4-5 hours <0.01 >0.05 <0.01 >0.05
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The Wilcoxon Signed Rank Sum Test was used to analyse the raw data (See Figure
4.2.3). Statistically significant differences were seen between the zero to five, three to
five and four to five hour samples in the experimental group (p = <0.01) as well as
between the zero to five hour, three to five and four to five hour samples in the control
group (p = <0.05). There was however no statistically significant difference between
any of the other groups compared in both the experimental and control groups (p =
>0.05).
Analysis using the Mann-Whitney Rank Sum Test also showed statistically significant
difference in the zero to five, three to five and four to five hour groups in the
experimental group (p = <0.01), as well as between the zero to five and three to five
hour groups in the control group (p =< 0.05). There was however no further statistically
significant difference between any of the other groups compared including the
comparisons made between the experimental and control groups (p = > 0.05).
Table 4.2.3.2 Results of Comparisons Between Groups at
Different Hours of Eosinophil Count
SAMPLE HOURS COMPARED MANN-WHITNEY RANK SUM TEST RESULTS
ohours NO ->0.05
3 hours NO->0.05
4 hours NO->0.05
5 hours NO->0.05
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4.3 Agranulocytes
4.3.1 Lymphocyte count from Cell-Dynn 1700 Analyser CS
Figure 4.3.1. Graph of Lymphocyte Count from Cell-Dynn 1700 CS
z:
~
~
-
~ 5
,.
o
0
.c
a.
E
:::
3
e
.Q
2
E
z
o
I M e d i c a Iio n I
_ P I. co bo
o 3 4 5
Tim e po st initial tream ent(H ours)
Table 4.3.1.1 Results of Lymphocyte Count from Cell-Dynn 1700 Analyser CS
WILCOXON SIGNED RANK TEST MANN-WHITNEY RANK SUM TEST
EXPERIMENT CO TROL EXPERIMENT CO TROL
GRO UP GRO UP GRO UP GROUP
0-3 hours <0.01 <0.01 >0.05 <0.05
0-4 hours >0.05 <0.01 >0.05 <0.05
0-5 hours <0.01 <0.01 >0.05 <0.05
3-4 hours >0.05 >0.05 >0.05 >0.05
3-5 hours >0.05 >0.05 >0.05 >0.05
4-5 hours >0.05 >0.05 >0.05 >0.05
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The Wilcoxon Signed Rank Sum Test showed a statistically significant difference
between the zero and three hour group in the experimental group (p = <0.01), as well as
and in the zero to three, zero to four and zero to five hour groups in the control group (p
= <0.01). The difference between the zero to three and zero to four hour groups in the
experimental group was not significant enough to rule chance out (p = >0.05). See
figure 4.3.1 for raw data in graph form. There was also no statistically significant
difference noted between the three to four, three to five and four to five hour groups in
both the experimental and control groups (p =>0.05).
Analysis using the Mann-Whitney Rank Sum Test showed statistically significant data
difference between the zero to three, zero to four and zero to five hour groups in the
control group (p = <0.05). This test however showed no statistically significant
difference between any of the other groups compared in both the control and
experimental groups, which also included the comparisons made between the two
groups (p =>0.05).
Table 4.3.1.2 Results of Lymphocyte Count from Cell-Dynn 1700 CS
SAMPLE HOURS COMPARED MANN-WHITNEY RANK SUM TEST RESULTS
ohours NO- >0.05
3 hours NO ->0.05
4 hours NO ->0.05
5 hours NO ->0.05
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4.3.2 Lymphocyte count from manual differential
Figure 4.3.2. Graph of Lymphocyte Count from Manual Differential
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Table 4.3.2 .1 Results of Lymphocyte Count from Manual Differential
WILCOXON SIGNED RANK TEST MANN-WmTNEY RANK SUM T EST
EXPERIMENT CO TROL EXPERIME T CONTROL
GROUP GROUP GROUP GROUP
0-3 hours >0.05 <0.01 >0.05 <0.05
0-4 hours >0.05 <0.05 >0.05 >0.05
0-5 hours >0.05 <0.01 >0.05 <0.05
3-4 hours >0.05 >0 .05 >0 .05 >0.05
3-5 hours >0.05 >0.05 >0.05 >0.05
4-5 hours >0.05 <0.05 >0.05 >0.05
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The Wilcoxon Signed Rank Test was used to analyse the raw data (See Figure 4.3.2).
This test showed no statistically significant difference between any of the groups in the
experimental group (p =>0.05). There was a significant difference shown between the
zero to three, four to five and zero to five hour groups (p =0.01) and between the zero to
four hour groups (p = <0.05) in the control group. There was however no further
significant difference in the three to four and three to five hour groups in the control
group (p = >0.05).
Analysis using the Mann-Whitney Rank Sum Test showed no statistically significant
difference in any of the groups compared in the experimental group (p = >0.05). This
test only revealed two statistically significant differences in the control group and that
was between the zero and three and zero to five hour group (p = <0.05). Where the
comparisons between the experimental and control groups were done a statistically
significant difference was seen between the zero hour groups (p = <0.05), but no other
difference was seen between the other groups compared (p =>0.05).
Table 4.3.2.2 Results of Comparisons Between Groups at
Different Hours of Lymphocyte Count from Manual
SAMPLE HOURS COMPARED MANN-WHITNEY RANK SUM TEST RESULTS
ohours YES - <0.05
3 hours NO ->0.05
4 hours NO ->0.05
5 hours NO ->0.05
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4.3.3 Atypical lymphocyte count from manual differential
Figure 4.3.3. Graph of Atypical Lymphocyte Count
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Table 4.3.3.1 Results of Atypical Lymphocyte Count from Manual Differential
WILCOXO SIG ED RA K TEST MA
-WHIT EY RA K SUM T EST
EXPERIME T CO TROL EXPERI IE T CO TROL
GRO P GRO P GRO P GROUP
0-3 hours <0.01 >0.05 >0.05 >0.05
0-4 hours >0.05 >0.05 >0.05 >0.05
0-5 hours >0.05 >0.05 >0.05 >0.05
3-4 hours >0.05 >0.05 >0.05 >0.05
3-5 hours >0.05 >0.05 >0.05 >0.05
4-5 hours >0.05 >0.05 >0.05 >0.05
The Wilcoxon Signed Rank Test showed statistically significant difference between the
zero and three hour sample in the experimental group (p = >0.01) indicating a
significant increase in the number of cells. There was however no statistically significant
difference between the zero to three hour group in the control group (p = >0.05), nor in
any of the other groups compared including the zero to four, zero to five, three to four,
three to five and four to five hour groups in both the experimental and control groups (p
=0.05). See figure 4.3.3 for raw data in a graph form.
The same comparative data analysis was then conducted using the Mann-Whitney Rank
Sum Test. This revealed no statistically significant difference within any of the groups
analysed (p = >0.05). The tests conducted between the experimental and control groups
showed a statistically significant difference between the three, four and five hour groups
(p = <0.01). It did, however, not show any difference between the zero hour groups (p =
>0.05).
Table 4.3.3.2 Results of Comparisons Between Groups at
Different Hours ofAtypical Lymphocyte Count
SAMPLE HOURS COMPARED MANN-WHITNEY RANK SUM TEST RESULTS
ohours NO ->0.05
3 hours YES - <0.01
4 hours YES - <0.01
5 hours YES - <0.05
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4.3.4 Monocyte count from manual differential
Figure 4.3.4 . Graph of Monocyte Count
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Table 4.3.4 .1 Results of Monocyte Count
WILCOXO SIG ED RA K T EST MA -WHIT EY RA K SUM T EST
EXPERIM E T CO TROL EXPERI 1£ T GROUP CO TROL
GRO P GRO P GRO P
0-3 hours >0.05 >0.05 >0.05 >0.05
0-4 hours <0.05 >0.05 <0.01 >0.05
0-5 hours >0.05 <0.01 >0.05 >0.05
3-4 hours <0.05 >0.05 >0.05 >0.05
3-5 hours <0.05 <0.01 <0.0 1 >0.05
4-5 hours <0.01 <0.05 <0.0 1 >0.05
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Analysis of the raw data (See Figure 4.3.4), was done using the Wilcoxon Signed Rank
Test. This revealed statistically significant differences between the zero to four, three to
four and three to five hour groups (p = <0.05) as well as between the four to five hour
group (p = <0.01) in the medicinal group. This test showed no statistically significant
difference between the zero to three hour group in the medicinal group (p = >0.05), nor
between the zero to three, zero to five and three to four hour groups in the control group
(p = >0.05). There was also no statistically significant difference between the zero to
three, zero to five and three to four hour groups in the control group (p = >0.05).
Further analysis using the Mann-Whitney Rank Sum Test showed no statistically
significant data difference in the control group as well as comparisons done between the
two groups. It did show a significant difference between the zero to four, three to five
and four to five hour groups (p = <0.01), and between the three to four hour group (p =
>0.05) in the experimental group. There was, however, no difference between the zero
to three (p =<0.01) and zero to five hour groups (p =>0.05) in the experimental group.
Comparisons between the groups showed no significant statistical difference (p =
>0.05).
T~ble 4.3.4.2 Results of Comparisons Between Groups at Different Hours of
Monocyte Count
SAMPLE HOURS COMPARED MANN-WHITNEY RANK SUM TEST RESULTS
ohours NO ->0.05
3 hours NO- >0.05
4 hours NO->0.05
5 hours NO ->0.05
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CHAPTERS
DISCUSSION OF RESULTS AND CONCLUSION
5.1 Total White Blood Cell Count
The Wilcoxon Signed Rank Test showed a statistically significant difference in the
medicinal group between the zero to three and zero to five-hour groups. The Mann-
Whitney Rank Sum Test did not show a difference in the zero to three-hour group, but it
did in the zero to five-hour group. It can thus be deduced that there was an increase in
the total WBC count proving the hypothesis. There was, however, also an increase
shown in the zero to three, zero to four, zero to five and three to four hour group
comparisons in the control group when the Wilcoxon Signed Rank Test was run. The
Mann-Whitney Rank Sum Test also showed a statistically significant difference in zero
to four and zero to five-hour group comparisons. This raises the question if the
combination of alcohol and colorant in the control group could have had a positive
effect on the circulating WBC's. These results in both groups then raises the question if
the homoeopathic remedies used in the experimental group had sole responsibility for
causing an increase in the total WBC count or if the alcohol or any other matter that was
present in both the groups had an effect. This opens the field for further research using a
longer time period and a larger group of volunteers.
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5.2 Neutrophil Count
5.2.1 Neutrophil Count from Cell-Dynn 1700 CS Analyser
The Wilcoxon Signed Rank Test showed a statistically significant difference in the zero
to five-hour group comparison in the experimental group. There was no other
statistically significant difference between any of the other comparisons made in the
experimental group including the comparisons made with the Mann-Whitney Rank Sum
Test. This again shows that over a trial period of five hours there was an increase in the
total number of circulating neutrophils. This result reinforces the effect that Thuja
occidentalis and Baptisia tinctoria has on bacteria (McKenna, 1997). Once again
statistically significant results were seen in the zero to three, zero to four, zero to five
and three to four hour group comparisons in the control group with the Wilcoxon Signed
Rank Test. This again raises the question of what the real ingredient was that caused an
increase in circulating neutrophils, and reiterates the need for further research over a
longer time period and with a larger group of subjects.
5.2.2 Neutrophil Count from Manual Differential
The Wilcoxon Signed Rank Test showed a statistically significant difference between
the three to five hour group comparison in the experimental group. The Mann-Whitney
Rank Sum Test showed no difference between any of the groups compared in the
experimental group. This indicates an increase in cells from three hours after the first
dose of medication had been ingested to five hours after the first dose, showing an
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increase in cells. This reinforces the results obtained with the neutrophil count obtained
from the Cell-Dynn 1700 CS Analyser. The Wilcoxon Signed Rank Test showed
statistically significant results between the zero to three, zero to four and zero to five
hour group comparisons in the control group. This increase in cells once again makes it
necessary to do further research, to investigate why there was an increase in the cells of
the control group and what substance could have had such an effect on the immune
system. The comparisons made between the experimental and control group showed
statistically significant differences between the zero hour groups but not between the
three, four and five hour groups. It thus started out with a difference and then the values
moved closer together excluding a significant difference - see graph 4.3.2. There was an
increase in the number of cells in the control group reiterating the need for further
research.
5.3 Eosinophil Count
The Wilcoxon Signed Rank Test showed a statistically significant difference between
the zero to five, three to five and four to five hour group comparisons in the
experimental group. There was, however, a decrease in the number of cells (See graph
4.2.3). The Mann-Whitney Rank Sum Test also showed a statistically significant
difference in the zero to five, three to five and four to five hour group comparisons in the
experimental group. In the control group the Wilcoxon Signed Rank Test showed a
statistically significant difference in the same groups as in the medicinal group and the
Mann-Whitney Rank Sum Test showed a difference between the zero to five and three
to five hour group comparisons. In both groups there was a decrease in the number of
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cells after five hours of having taken either the placebo or experimental substance. This
raises the question of what could be the substance that was having such an effect on the
eosinophils? A decrease in eosinophils during a very severe allergic episode (Moffet et
ill.. 1993) can surely be of benefit to the patient and further research is needed with a
larger number ofvolunteers and over a longer period of time.
5.4 Lymphocyte Count
5.4.1 Lymphocyte Count from Cell-Dynn 1700 CS Analyser
The Wilcoxon Signed Rank Test showed a statistically significant difference in the
experimental group between the zero to three and zero to five hour group comparisons.
The Mann-Whitney Rank Sum Test showed no statistically significant difference
between any of the groups compared in the experimental group. The control group
showed statistically significant differences between the zero to three, zero to four and
zero to five hour group comparisons with both the Wilcoxon Signed Rank and the
Mann-Whitney Rank Sum Tests. When a virus infection occurs the lymphocytes become
activated and move into the tissues which leads to an inversed ratio of lymphocytes
(Guyton, 1992). Initially though, when activated, there is an increase in the number of
lymphocytes. These results indicate the need for further research over a longer time
period and a larger group ofvolunteers.
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5.4.2 Lymphocyte Count from Manual Differential
There was no statistically significant difference between any of the hour groups
compared in the experimental group using both the Wilcoxon Signed Rank Test and the
Mann-Whitney Rank Sum Test. In the control group there was a statistically significant
difference between the zero to three, zero to four and zero to five hour groups with the
Wilcoxon Signed Rank Test. With the Mann-Whitney Rank Sum Test there was a
statistically significant difference between the zero to three and zero to five-hour groups.
The comparisons made between the experimental and control groups showed a
statistically significant difference between the zero hour groups. These results reiterate
the need for further research as was mentioned in 5.4.1.
5.4.3 Atypical Lymphocyte Count
There was only one statistically significant result in both the experimental and control
group. This was between the zero to three-hour group comparison in the experimental
group using the Wilcoxon Signed Rank Test. The only other results obtained were with
the Mann-Whitney Rank Sum Test between the experimental and control group between
the three, four and five hour groups. Further research is required to validate these results.
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5.5 Monocyte Count
The Wilcoxon Signed Rank Test showed statistically significant differences between the
zero to four, three to four, three to five and four to five hour group comparisons in the
experimental group. The Mann-Whitney Rank Sum Test also showed a statistically
significant difference between the groups mentioned above. The Wilcoxon Signed Rank
Test showed statistically significant differences between the zero to five, three to five
and four to five hour group comparisons in the control group with no results obtained in
the Mann-Whitney Rank Sum Test. There was a drop in the number of cells between the
three and four hour groups with an increase in the number of cells between the four and
five hour groups (See Figure 4.3.4). In Marieb (1992) it is stated that monocytes act in
the phagocytosis of foreign matter and in activation of lymphocytes. The increase in
monocytes was seen in both groups and once again further research, over a longer time
period with a larger group ofvolunteers, is required to validate results obtained.
5.6 Conclusion
The increase in the total WBC count has proved the hypotheses that Baptisia tinctoria
mother tincture and Thuja occidentalis D1 will cause an increase in the total number of
circulating WBC's. The increased numbers of neutrophils reinforces the anti-bacterial
action of Baptisia tinctoria as stated in Jouanny (1994) and McKenna (1997). The
decrease in the number of eosinophils concurs with the anti-cattarhal effect of Baptisia
tinctoria (McKenna, 1997). The increase in number of lymphocytes reinforced the anti-
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viral properties of both the remedies used in the research as stated by Jouanny (1994),
McKenna (1997) and in recent research done on TPSg an extract made from Thuja
occidentalis by Hassan (1996). There was an eventual increase in the number of
monocytes but the initial decrease in numbers shows the need for more research over a
longer time period. These results would have been promising, had not the results in both
experimental group and control group been so similar. This raises the question as to
whether substances common to both experimental and control groups may have caused
the effect. The need for further research over a longer time period and with a larger
volunteer group is required to validate these results.
No relevant research has been done on Thuja and Baptisia in high potency to validate
these results homoeopathically. Results found in McKenna (1997), of Baptisia tinetoria
causing an increase in lymphocytes, have confirmed that further research is required.
As a result of the need for further research the researcher could thus not establish if
homoeopathic medicines when used in a complex formulae acts more rapidly than when
used in a simplex form.
5.7 Recommendations
It is recommended that to truly validate these results, further research is needed with a
larger group of volunteers over a longer period of time. To make this a true
homoeopathic study, research has to be done using higher potencies (beyond Avagadro's
number) to see the effect of the remedies when used alone and in complex form, taking
into account symptoms on all three levels of the body.
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APPENDIX A
PAT1ENTCO~SENTFORM
FULLKAME.
ADDRESS: _
TELEPHO~NU\mER: _
AGE: ~
I. the undersigned, hereby agree to participate voluntarily in the research program on the
effect of homoeopathic medicine on white blood cells conducted through the Technikon
WitwatCISl'lllld.
1acknowledge that the treatment J receive is upon the understanding thai it is used for
research purposes. ] ha...e bt:en advised that the treatment and placebo both contain 20%.
alcohol and. confirm that I do not have a history ofalcoholism.
1 fully understand that ] l11lIy be assigned to a placebo group. and that all information that
1 volunteer \I<'ill be regarded as confidential.
N.4M"~OF FOLlJh7Ff.R : ...,-_
SIGNATURE:
D.411-:: ~ _
NAME OFRESEARCHER:._
SJGNATURE: _
DAn; z _
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INFOR1\-JATJON ANI) CONSENT FORI'1 FOR
HESEARCH SlJB.JECTS
TIll: Ii:~c,udl PI(~I..'\:1 lOI ....)~dl }lY..I b~\''':: volunteen..d involves the usc ofa nc\,,'l}"
developed ccmbination ofhvmocop.l::llc m;,:-:i:::im:.. The individd constituents of ~;b
substance have been '..sed Ior ccntunes as tr.ldifiou.llll".cdicillal herbs, l:lrgcJy as antiseptics
and 3;lli-i;lfecti~~agems. We are requestingyou (.) participate in a research ~udy which
\..ill a:i1>i~ u:sin l.:.,rningwhether III\: C,Hllbillaliol: of these substances \..i;] be hclpl~l ill tit..:
1)1 .."\l,.'UliIJOl \)1' m~-':Lt.,m b~ in...·r~;I':>jn:.~ ,;11:- ;,pi!.ty i1ftb: b:a.llh bn~y h) t;';;:l1 infection
ShlKJU )"'0'.' IQnicip:ltc. )'ll,l '...it LJt.: a~h-J 101m'.: a bloodsam;lc l.u.,,·;t for I~ting
purposes
Sl;bseq"Cllt to tltal }OU \.. iIl receive 100 drops of the substance, Tras wJI be fottowcl ~y
foor d;JSCS ofjG drops each, :It 1~)Il~ live minute intervals A total or ti\'~ doses 0, 300
drops will be administered OWl three hours. V~n:; the scale of 1011 is c~u.ll to 16 drc~$.
tin: tvlal volurnc cf Ill\.-Ji..:aliun \,)1 pld~c~o adn:iOl:;tc;c,; would thus be 13.75 mls, t\:l~
the bs:.dose ofmedicatil);l 01' placebo is taken a secondblood s..unple ',.ill be taken. T\\:)
metre blood samples wit then be t<lJ...:a tlcm yOJ at hourly intervals. Taus a rota, l~t' ~'l.'~
blood sau.plcs will be required ((\olJll lVU over t;"c six hour trial period.
The drops which lOU will be given \~iIl either be active or inactive For purposes of the
research, neither }'ClII no: anyone else at the Clinic will know which Ihl\ e been
administered to you tallho.:~h that informationnill be on file at the research co-crdinatieg
centre and can be made available tu ycur ph)'~ici.);l i:·neo.-ccJ)
Your h;ooo samples w.ll be:lSSC:iS\..-d bya laboratory, and important information from
these samples \\i:J be used f,,'f the f>'.Lrp(l~S of the study and sent to the research co-
oldinat;ng 'C11:t~
PreViOUS usc of the constituent substances have shown their effect in stimulating the
immune &ptc:m oftb: hwnau body. No adverse dTcl:t:!o have been reported due to the use
of'thcse substances in the concentrations thai willbe used III this study
1111: potential benefits for t:-t;)~ w bo receive :;lC stucy medicines are Iholl the iUl;lrJIJe
systemof the hody milY hi: ~limu!al.cJ It) generate more ..vhitc blood cells. This may
increase Iht~ abi~i:y of tite I:cahh human l.md)' to light of:·infcnior. R(,~:lrdlcssof the
substance ~i~I\.'\f • .1:1 patients \\ /1-,) ~l.l;li':l;iltc In tl:l) ~tud~' w Ill contribute [0 ;n~;;i.;;al
knowledge, resulting :hc selection of improved methodsof md:cationtc -COr.l~t
inlcCli:m
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Participationin the ~tudy is vul,..ntaiy and you are free 10 refuse to participate or to
'A;thdraw your consent and to diSC\>lltinuc parlil:iJhlticll ..1.m:, lime. Such refJ»l or
d.scontiauance 'will not affect your n:gubr treatmentsor medical care 111 a:lY w~r A
signed ropy of this consent fonn willbe /ludt:: available to )OU.
-.-------------------------------
1 ha..'C futlycxplaim.'d Ihe procedsres, iCentifjint those \\nitb arc im't:Sli~ationaJ, and have
explainedtheir purpose. 1ha..'c asked whether or not any questions havearisen cCg;lrdi.,g
tbc procedures, and have ans....-ered thosc quesnoes to llle bestofmy ability.
D.:lte 1998
11>.a,,<: been lul:y i.llronn~ as to the procedures to be followed, ind'.:.din-~ those which are
investigationa! and have been ~i\icn a description of the ;dlcml,uil tJi.;.cuuuoct:), (i~s and
benefits to be expected, In sign;n~ this consent form 1agree to the method of treatmen;
and I understand that I am Irec to withdraw Illy consent "'lhi withdraw my participation in
this study ill <lily lime. I further understand that if I have any 'iue"Slivl1~ at any lime. they
willbe funy 1lJl5.... ercd,
Date 1998 Participanl
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APPENDIXB
DOM LABDRATOR'I'
CD170(1 SPECIMEN DATA REPORT
REFERENCE RANGE (LIMIT I)
140. - 400. K/uL
6.9 - 9'3.1> fL
3.70 -
11.4
36.0
60.0 -
26.'3 -
30.'3 -
11. ~ -
Specilt8~n ID# 4
Patient: 4
Sex: F DOB:
Phy",ician: H
Co ...ents:
TES' RESULT
WBC 6.2 K/uL
LYM 3.1 ~"_J ~L
MID 0.4 f..l ~PI
GRAN 2.7 43.0 :'{G
jiBe 4.47 M/uL
HGB 13.3 g/dL
HeT 38.5 'l:.
MeV 8&.2 fL
tolCH 29.8 pg
MCHC 34.5 g/dL
ROW 13.4 ~
PU 392. K/uL
1'1PV 8.7 fL
FLAG LIMIT
[* J
l ."J
[* J
[* J
[* l
(* l
(* l
[.. J[ * l
[ *l
[ .. J
Analyzed: 18/03/98 11:28
Uperator 1.0. :---
Sequence ~: 2091
Mode: Open X-B: 10;OUT2
Collected: 09/19 14:00
3.9 - 1-' I KiuLc.
(l.b 4. 1 13.0 - 4&.0 -;'l
0.0 1.8 0. 1 - 12 .. 0 AM
2.0 - 7.8 39.. 0 - 7G.O l'G
b. be. M/uL
18.5 g/dL
55.0 ;4
99.0 fL
32.5 ..,g
3b.0 g/dL
15.5 ~
... MID cells .ay lnclude less frequently occurring and rare cells correlatll'Y tL
llIonoc-ytes, e o s r nopn t j s , b«sophil,>, bla,>t':> ",od other' prec\rJ"sor whlte cells.
ttl
\ollie
RBe
PLT
5.&5 s
5. &1 s
11A!'AA1L DIFFERENTIAL MORPHOLOGY 2 3 4
5£6
'"
POL'iCHROtl [ ) ) 1
BAND ,; HVPOCHROI'I ( ) ] )
lYMP ,; I:'OIK ( 1 1 1 1
MONO :4 TARGET [ 1 ) )
EOSIN ;.; S~'HERO ( 1 ) )
BASO J' ANISO [ ) ) )
'JAR lYM
"
MICRO ( ) ) )
MEW
"
I'IACRO [ ) )
PRQ MYLO ,; BASO SlIP [ ) J )
BlAS'f
"
vACUOlES ( ) )
TOXIC GRAN ( 1
PLT EST
------
PLT MORrH
COMt'.ENTS
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APPENDIXC
NATURA LABORATORIES
Method of Manufacture of complex Baptisia tinctoria mother tincture and Thuja
occidentalis Dl:
Thuja occidentalis Dl was prepared from Thuja occidentalis mother tincture (98RD48).
A one in ten dilution in 62% alcohol was used.
Thuja occidentalis mother tincture (98RD48)
Alcohol 62%
Potentize ten times by hand
Dl = 330ml
Thuja occidentalis Dl
Baptisia mother tincture (98RI29)
Mix thoroughly.
33ml
297ml
330ml
330ml
330ml
660ml
Method of Manufacture of Placebo:
20% Alcohol
Tartrazine Free Water soluble hexacol colouring green, yellow, and brown.
This information was obtained from Natura Laboratories on the 1st of July 1999.
62
APPENDIXD
NATURA LABORATORIES
ANALYTICAL REPORT FOR RAW MATERIALS
Raw material: Thuja occidentalis mother tincture
In House Batch No: 98RD48
Supplier: Dolisos
Suppliers Batch No: LM22802
Date: 28-4-98
Expiry Date: 05-2002
TEST METHOD SPECIFICATION RESULTS
Appearance French Clear dark greenish brown liquid Complies
Pharmacopoeia
(January 1989)
Odour French Aromatic odour Complies
Pharmacopoeia
(January 1989)
PH 5,50
R.L 1,3650
R.D. 0,9023
Identification French Complies
Pharmacopoeia
(January 1989)
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Released by: A. Matthews Date: 30-4-98 Release sticker: A. Matthews
NATURA LABORATORIES
ANALYTICAL REPORT FOR RAW MATERIALS
Raw material: Baptisia tinctoria mother tincture
In House Batch No: 98RI29
Supplier: Parceval
Suppliers Batch No: 06835
Date: 7-9-98
Expiry Date: 09-2001
TEST METHOD SPECIFICATION RESULTS
Appearance Clear dark amber liquid complies
Odour Herbal odour complies
PH 6,05
R.I. 1,3658
R.D. 0,8844
Released by: L. Stoffly Date: 8-9-98 Release sticker: L. Stoffly
Analytical reports for Thuja occidentalis mother tincture and Baptisia tinctoria mother tincture
was received from Natura Laboratories on the 15t of July 1999.
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